Toggle Offcanvas
...
 
Paliperidone Tenders

Paliperidone Tenders

View Paliperidone tenders, RFPs and contracts. Bid on readily available Paliperidone tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Paliperidone tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Paliperidone.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Paliperidone market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Paliperidone tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

137 Live Notices for Paliperidone Tenders

Showing 1 to 20

Object: Electronic Auction - Price Registration For Future Medicines Acquisition - Judicial Demand 47. Protocol No. 23.236.634-5
country Brazil
posting date14 Mar 2025
deadline28 Mar 2025
Supply Of Palmitato Palmita Im Sir 100Mg (Purchase To Damage Immediate Availability) For Info 035/3064372
country Italy
posting date11 Mar 2025
deadline13 Mar 2025
Supply Of Palmitato Palmita Im Sir 150Mg (Purchase To Damage Immediate Availability) For Info 035/3064372
country Italy
posting date11 Mar 2025
deadline13 Mar 2025
Paliperidone Palmitate 100 Mg/Ml Sus Inj Lib Prol Im Ct 1 Being Plas Coc Trans X 1.50 Ml + 2 Agu *
country Brazil
posting date07 Mar 2025
deadline24 Mar 2025
Supply Of Paliperidone Medicines (Doe) Parenteral In Quarterly Formulation And Selexipag (Doe) For All Osakidetza Service Organizations And Linked Health Centers
country Spain
posting date04 Mar 2025
deadline19 Mar 2025
Suministro De Lacosamida (Doen), Vinorelbina (Doen), Erepapenem (Diy), Voriconazole (Doen), Ontantron (Doen), Ephedrina (Doen), Paliperidona (Doen), Atropina (Do) Y Epinefrina (Do)
country Spain
posting date27 Feb 2025
deadline14 Mar 2025
Injectable Paliperidone Supply For The Miguel Servet University Hospital In Zaragoza And Zaragoza Defense Hospital
country Spain
posting date26 Feb 2025
deadline13 Mar 2025
* Price Registration * Price Registration For The Supply Of Medicine Lawsuit - Paliperidone Palmitate 100 Mg / 1.0 Ml And Paliperidone Palmitate 150 Mg / 1.5 Ml
country Brazil
posting date20 Feb 2025
deadline14 Mar 2025
Delivery Of Medicines For The District Hospital In Chrzanów
country Poland
posting date13 Feb 2025
deadline20 Mar 2025
Securing Medicine Items For King Saud University Medical City
country Saudi Arabia
posting date05 Feb 2025
deadline02 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date05 Dec 2024
deadline05 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date26 Nov 2024
deadline05 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (N05Ax13) And The Trade Name Trevicta® As Part Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (N05Ax13) And The Trade Name Trevicta® As Part Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone – Only Depot Injection Suspensions For Three-Month Dosing (Atc Code: N05Ax13).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone - Only Depot Injection Suspensions For Three-Month Dosing (Atc Code: N05Ax13).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026

Share Share this page